Timolol ophthalmic solution is usually well tolerated. The following adverse reactions have been reported.
Urogenital: Urination difficulties.
In addition, a variety of adverse effects have been reported with other beta-adrenergic blocking agents and may be considered potential effects of ophthalmic Timolol maleate: Digestive: Mesentric arterial thrombosis, ischaemic colitis.
Haematologic: Agranulocytosis, thrombocytopenic purpura.
Nervous System: Reversible mental depression progressing to catatonia, an acute reversible syndrome characterized by disorientation for time and place, short-term memory loss, emotional lability, slightly clouded sensorium and decreased performance on neuropsychometrics.
Allergic: Erythematous rash, fever combined with aching and sore throat, laryngospasm with respiratory distress.
Urogenital: Peyronie's disease.
There have been reports of a syndrome comprising psoriasis skin rash, conjunctivitis sicca, otitis and sclerosing serositis attributed to the beta-adrenergic receptor blocking agent, practolol. This syndrome has been reported with Timolol maleate.
View ADR Reporting Link